Investor Presentaiton
Purpose and
sustainability
کے
༢
Commercial
execution
Strategic aspirations 2025
•
•
Being respected for adding value to society
.
Progress towards zero environmental impact
Ensure distinct core capabilities and evolve culture
•
Strengthen Diabetes leadership - aim at global value
market share of more than 1/3
Strengthen Obesity leadership and more than double
current sales¹
•
Secure a sustained growth outlook for Biopharm
Financials
Innovation and
therapeutic focus
R&D investor presentation
•
•
•
Further raise the innovation-bar for diabetes
treatment
Develop a leading portfolio of superior treatment
solutions for obesity
Strengthen and progress the Biopharm pipeline
Establish presence in other serious chronic
diseases focusing on CVD, NASH and CKD
•
Deliver solid sales and operating profit growth
•
Deliver 6-10% sales growth in IO
•
•
• Transform 70% of sales in the USA²
Drive operational efficiencies across the value
chain to enable investments in future growth
assets
Deliver free cash flow to enable attractive capital
allocation to shareholders
1 Based on reported sales in 2019, 2 From 2015 to 2022. IO: International Operatons; CVD: Cardiovascular disease; NASH: Non-alcoholic steatohepatitis; CKD: Chronic kidney disease.View entire presentation